Enable JavaScript to visit this website.

time-is-of-the-essence

cyanokit

Time is of the essence

Signs and symptoms of acute systemic cyanide poisoning may develop rapidly, depending on the route and extent of cyanide exposure.1 If cyanide poisoning is known or suspected, treat with CYANOKIT— an FDA-approved treatment option for cyanide poisoning.1

Key facts about CYANOKIT:

  • CYANOKIT 5 g for intravenous infusion is indicated for the treatment of known or suspected cyanide poisoning. If clinical suspicion of cyanide poisoning is high, CYANOKIT should be administered without delay1
  • CYANOKIT can be used to treat multiple sources of cyanide poisoning including smoke inhalation and ingestion1
  • Hydroxocobalamin, the active ingredient in CYANOKIT, has been used in France since the 1980s, was formally licensed there in 1996, and was approved in the United States in 2006 to treat known or suspected cyanide poisoning3,14

Clinical Experience

Randomized clinical trials in humans are not possible due to ethical considerations, therefore evidence in controlled trials of the effectiveness of hydroxocobalamin for the treatment of cyanide poisoning was obtained primarily from studies in animals.4 However, 4 open-label, uncontrolled clinical studies were conducted in known or suspected cyanide poisoning victims.1

Experience in Known or Suspected Cyanide Poisoning Victims

A total of 245 patients received hydroxocobalamin treatment in these studies. Systematic collection of adverse events was not done in all of these studies and interpretation of causality is limited due to the lack of a control group and due to circumstances of administration (eg, use in fire victims). Adverse reactions reported in these studies listed by system organ class included1:

  • Cardiac disorders: ventricular extrasystoles
  • Investigations: electrocardiogram repolarization abnormality, heart rate increased
  • Respiratory, thoracic, and mediastinal disorders: pleural effusion

Smoke inhalation studies

A prospective, uncontrolled, open-label study spanning almost 7 years was carried out in 69 subjects who had been exposed to smoke inhalation from fires. Subjects had to be over 15 years of age, present with soot in the mouth, and have altered neurological status. The presence of cyanide poisoning, defined by a pretreatment blood cyanide concentration greater than or equal to 39 µmol/L was confirmed in 42 of the 63 patients with evaluable data (67%). The median hydroxocobalamin dose was 5 g with a range from 4 g to 15 g.

Following the administration of hydroxocobalamin, 50 of 69 subjects with cyanide poisoning (73%) survived.1,3

The most common adverse events for this study were chromaturia (n=6), pink or red skin discoloration (n=4), hypertension (n=3), erythema (n=2), and increased blood pressure (n=2).3

Two additional retrospective, uncontrolled studies were carried out in subjects who had been exposed to cyanide from fire or smoke inhalation. Subjects were treated with up to 15 g of hydroxocobalamin. Survival in these two studies was 34 of 61 (56%) for one study, and 30 of 72 (42%) for the second.1

Ingestion or inhalation study

A retrospective chart review over a period of 15 years was compiled by identifying 14 patients who had been exposed to cyanide from sources other than from fire or smoke (ie, ingestion or inhalation). Subjects were treated with 5 g to 20 g of hydroxocobalamin. Eleven of 12 subjects whose blood cyanide concentration was known had initial blood cyanide levels considered to be above the lethal threshold.

Following the administration of hydroxocobalamin, 10 of 14 subjects with cyanide poisoning (71%) survived.1,8

In this study, adverse events considered possibly to be caused by hydroxocobalamin were chromaturia (n=5), pink-to-red skin discoloration (n=3), increase in heart rate (n=1), and elevated blood pressure (n=1).8

Selected Safety Information

  • Use caution in the management of patients with known anaphylactic reactions to hydroxocobalamin or cyanocobalamin
  • Allergic reactions may include: anaphylaxis, chest tightness, edema, urticaria, pruritus, dyspnea, and rash. Allergic reactions including angioneurotic edema have also been reported in postmarketing experience
  • Acute renal failure with acute tubular necrosis, renal impairment, and urine calcium oxalate crystals have been reported following CYANOKIT therapy. Monitor renal function for 7 days following CYANOKIT therapy.
  • Substantial increases in blood pressure may occur following CYANOKIT therapy. Usage may interfere with some clinical laboratory evaluations

Adverse Event or Product Quality Complaints
If you wish to report an adverse event or product quality complaint, please call: 1-800-438-1985.

Medical Information
If you have a medical question concerning Meridian products, please call 1-800-438-1985. US HCPs can visit www.pfizermedinfo.com.

CYANOKIT.com | Treatment with CYANOKIT

How CYANOKIT Works

How CYANOKIT Works

Cyanide poisoning prevents cells from using oxygen

The ability of oxygen to access the cytochrome oxidase enzyme (present on the mitochondria inside cells) is essential to normal, life-sustaining cellular respiration. Cyanide poisoning may disable the body’s ability to use oxygen, so it can be fatal despite the amount of oxygen available to the body.1

Without treatment, exposure to a high dose of cyanide may result in death within minutes1 and may also cause central nervous system side effects including altered mental status, parkinsonism, and personality changes.7

Studies show that the concentration of plasma lactate increases with the severity of cyanide poisoning and that hydroxocobalamin treatment results in rapid resolution of cyanide-induced lactic acidemia.6

Treat known or suspected cyanide poisoning with CYANOKIT

CYANOKIT (hydroxocobalamin for injection) is a cyanide antidote that contains hydroxocobalamin, a form of vitamin B12. Hydroxocobalamin binds to cyanide, creating nontoxic cyanocobalamin, allowing the body to use oxygen again.1



Watch the video to learn more about how cyanide and CYANOKIT work in the body.

 

 

Adverse Event or Product Quality Complaints
If you wish to report an adverse event or product quality complaint, please call: 1-800-438-1985.

Medical Information
If you have a medical question concerning Meridian products, please call 1-800-438-1985.
US HCPs can visit www.pfizermedinfo.com.

 

CYANOKIT.com | How CYANOKIT works

The Components of each CYANOKIT

The Components of each CYANOKIT

The Components of each CYANOKIT

NDCCarton Dimensions
11704-370-01W: 7.64" x L: 3.94" x H: 3.82"

Adverse Event or Product Quality Complaints
If you wish to report an adverse event or product quality complaint, please call: 1-800-438-1985.

Medical Information
If you have a medical question concerning Meridian products, please call 1-800-438-1985. US HCPs can visit www.pfizermedinfo.com.

 

CYANOKIT.com | Components of CYANOKIT

Dosing and Administration for CYANOKIT

Dosing and Administration for CYANOKIT

Learn how to dose and administer CYANOKIT

 

Recommended dosing for CYANOKIT1

  • The starting dose of CYANOKIT for adults is 5 g (contained in a single vial), administered by IV infusion over 15 minutes (approximately 15 mL/min) *
  • Depending upon the severity of the poisoning and the clinical response, a second dose of 5 g may be administered by IV infusion up to a total dose of 10 g
  • The rate of infusion for a potential second dose may range from 15 minutes (for patients in extremis) to 2 hours, as clinically indicated


    *No safety and efficacy studies have been performed in pediatric patients.

Preparation and administration1

Starting dose: 5 g
  1. Reconstitute: Place the vial in an upright position. Add 200 mL of 0.9% Sodium Chloride injection* to the vial using the transfer spike. Fill to the line.

    *0.9% Sodium Chloride injection is the recommended diluent (diluent not included in the kit). Lactated Ringer’s injection and 5% Dextrose injection have also been found to be compatible with hydroxocobalamin and may be used if 0.9% Sodium Chloride is not readily available.

  2. Mix: The vial should be repeatedly inverted or rocked, not shaken, for at least 60 seconds prior to infusion.
    • CYANOKIT solutions should be visually inspected for particulate matter and color prior to administration
      • — Discard solution if particulate matter is present or solution is not dark red
  3. Infuse Vial:  Use vented intravenous tubing, hang and infuse over 15 minutes.

 

How to administer CYANOKIT in 3 steps


Caution should be exercised when administering other cyanide antidotes simultaneously with CYANOKIT, as safety has not been established. If a decision is made to administer another cyanide antidote with CYANOKIT, these drugs should not be administered concurrently in the same IV line.

 

CYANOKIT Incompatibility Information1

Physical incompatibility (particle formation) and chemical incompatibility were observed with the mixture of hydroxocobalamin in solution with select drugs that are frequently used in resuscitation efforts. Hydroxocobalamin is also chemically incompatible with sodium thiosulfate and sodium nitrite and has been reported to be incompatible with ascorbic acid. Therefore, these and other drugs should not be administered simultaneously through the same intravenous line as hydroxocobalamin.

Simultaneous administration of hydroxocobalamin and blood products (whole blood, packed red cells, platelet concentrate and/or fresh frozen plasma) through the same intravenous line is not recommended. However, blood products and hydroxocobalamin can be administered simultaneously using separate intravenous lines (preferably on contralateral extremities, if peripheral lines are being used).

Adverse Event or Product Quality Complaints
If you wish to report an adverse event or product quality complaint, please call: 1-800-438-1985.

Medical Information
If you have a medical question concerning Meridian products, please call 1-800-438-1985.
US HCPs can visit www.pfizermedinfo.com.

 

CYANOKIT.com | Dosing and Administration

Storing CYANOKIT

Storing CYANOKIT1

To use CYANOKIT properly, follow these important storage and handling guidelines.

Lyophilized form: Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). CYANOKIT may be exposed, during short periods, to temperature variations of usual transport, transport in the desert, and freezing/defrosting cycles.

  • Usual transport defined as 15 days subjected to temperatures ranging from 5°C to 40°C (41°F to 104°F)
  • Transport in the desert defined as 4 days subjected to temperatures ranging from 5°C to 60°C (41°F to 140°F)
  • Freezing/defrosting cycles defined as 15 days subjected to temperatures ranging from -20°C to 40°C (-4°F to 104°F)

Storage of Reconstituted Drug Product: Once reconstituted, hydroxocobalamin is stable for up to 6 hours at temperatures not exceeding 40°C (104°F). Do not freeze. Any reconstituted product not used by 6 hours should be discarded.

Please see full Prescribing Information for complete instructions regarding dosing, preparation, administration, incompatibility, and storage information.

Adverse Event or Product Quality Complaints
If you wish to report an adverse event or product quality complaint, please call: 1-800-438-1985.

Medical Information
If you have a medical question concerning Meridian products, please call 1-800-438-1985.
US HCPs can visit www.pfizermedinfo.com.

 

 

CYANOKIT.com | Storage and Handling